Catherine Novack
Stock Analyst at Jones Trading
(1.98)
# 3,023
Out of 5,182 analysts
25
Total ratings
23.81%
Success rate
3.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DTIL Precision BioSciences | Assumes: Buy | $30 | $7.45 | +302.68% | 1 | Apr 17, 2026 | |
| IBIO iBio, Inc. | Initiates: Buy | $7 | $1.61 | +334.78% | 1 | Mar 3, 2026 | |
| SEPN Septerna | Initiates: Buy | $43 | $24.10 | +78.42% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $12.59 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $5.47 | +503.29% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $17.47 | +71.72% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $32.96 | -12.01% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.40 | +1,401.88% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $14.28 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $129.47 | -65.24% | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.63 | +574.85% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.07 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $7.18 | +122.84% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.01 | +249.13% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $3.27 | +297.55% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.29 | +203.95% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.60 | +3,557.52% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.34 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,600 | $4.22 | +37,814.69% | 1 | Jul 21, 2023 |
Precision BioSciences
Apr 17, 2026
Assumes: Buy
Price Target: $30
Current: $7.45
Upside: +302.68%
iBio, Inc.
Mar 3, 2026
Initiates: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $24.10
Upside: +78.42%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $12.59
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $5.47
Upside: +503.29%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $17.47
Upside: +71.72%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $32.96
Upside: -12.01%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.40
Upside: +1,401.88%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.28
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $129.47
Upside: -65.24%
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.63
Upside: +574.85%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.07
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.18
Upside: +122.84%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.01
Upside: +249.13%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $3.27
Upside: +297.55%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.29
Upside: +203.95%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $0.60
Upside: +3,557.52%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.34
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $1,600
Current: $4.22
Upside: +37,814.69%